A Phase II Study of Capecitabine, Oxaliplatin, and Bevacizumab in the Treatment of Metastatic Esophagogastric Adenocarcinomas

BACKGROUND. Esophageal and gastric cancers often present at an advanced stage. Systemic chemotherapy is the mainstay of treatment, but survival with current regimens remains poor. We evaluated the safety, tolerability, and efficacy of the combination capecitabine, oxaliplatin, and bevacizumab in the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Uronis, Hope E., Bendell, Johanna C., Altomare, Ivy, Blobe, Gerard C., Hsu, S. David, Morse, Michael A., Pang, Herbert, Zafar, S. Yousuf, Conkling, Paul, Favaro, Justin, Arrowood, Christy C., Cushman, Stephanie M., Meadows, Kellen L., Brady, John C., Nixon, Andrew B., Hurwitz, Herbert I.
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2013
Assuntos:
Clinical Trial Results
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3607522/
https://ncbi.nlm.nih.gov/pubmed/23485624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0404
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados